Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01 in Noninfectious Uveitis
![Tarsier Pharma TRS01: FDA Approves Uveitis Treatment](https://wellnessnews24.com/wp-content/uploads/2023/11/Tarsier_Pharma_1-600x530.jpg)
2 min read
Tarsier Pharma, Ltd., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing first-in-class new therapies for...